• PathXL Xplore

  • PathXL with HALO

  • Blog: PathXL eats big data for breakfast

  • Financial Times feature PathXL

  • Introducing TissueMark powered by PathXL

  • TissueMark wins top Frost and Sullivan award

Excellence in tumor analysis 

We recognise that digital pathology is moving from an era of point solutions to much greater maturity - transforming entire workflows in education, research and ultimately clinical use. We intend to become recognised as the visionaries and leaders in tumor analysis.

Digital Pathology

PathXL is a global pioneer in the use of web-based solutions for digital pathology.  Specialising in image management and the rapid analysis of tumor tissue, the company provides innovative software for use in drug discovery research, clinical sectors, biomarker analysis and education.

Read the latest post from PathXL our newly launched blog.

Tissuemark®

tmRight

Watch our video on TissueMark and request further information on our exciting new product.

nikon.jpgolympus.jpgklinipath.jpginter.jpgvisiopharm.jpgoptatech.jpgmason.jpgindica.jpgLRI.jpgonq.jpg
kwazulu.jpgmayoclinic.jpgicgc.jpgunicopenhagen.jpgaalborg.jpgblpg.jpgimperial.jpgnib.jpgoxford.jpgchernobyl.jpgoncomark.jpgmesobank.jpgvisicort.jpgstvincents.jpglondondeanery.jpgunioulu.jpgwalescancerbank.jpguniwestminster.jpgutmb.jpgimpact.jpgnuig.jpgfloride.jpgispwiv.jpgcambridge.jpgguys.jpgicr.jpgesp.jpghistotox.jpggiessen.jpgnordiqc.jpgqub.jpgnottingham.jpgucla.jpgbarts.jpgstjames.jpgpathsoc.jpgtrinity.jpgcleveland.jpg

deloitte deloitte   frost-sullivan   frost-sullivan